The Drugs Controller General of India has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila......
Human clinical trials for a vaccine for COVID-19 has been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed......
Union health ministry officials on Thursday clarified that the intent of the Indian Council of Medical Research director general's letter envisaging the launch of COVID-19 vaccine by August 15 was......
As India gears up for the world's largest vaccination programme, the ministry of health and family welfare addressed apprehensions expressed by the public regarding the COVID-19 vaccine's......
If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini......
Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug......
Cadila Healthcare said on Thursday it has received approval from the US health regulator to carry out clinical trials of its new drug molecule, ZYGK1, aimed at treating diabetes.Approval was given......
Forget kapda aur makaan. After food and groceries, Indians are said to be spending the maximum amount on healthcare and beauty.According to healthcare industry estimates, the total private......
The Indian Pharmaceutical Alliance, the association of the country's leading domestic drug producers, has sounded the alarm bells against foreign companies acquiring homegrown players. In fact, it......
The country's leading companies came together recently to discuss the HR challenges thrown at them in the backdrop of the global meltdown at a seminar 'HR challenges -- coping with the economic......